How does gjb2 cause hearing loss

Content on WhatAnswers is provided "as is" for informational purposes. While we strive for accuracy, we make no guarantees. Content is AI-assisted and should not be used as professional advice.

Last updated: April 8, 2026

Quick Answer: GJB2 gene mutations cause hearing loss by disrupting the production of connexin 26, a protein essential for potassium ion recycling in the cochlea. These mutations account for up to 50% of cases of nonsyndromic sensorineural hearing loss in many populations. Over 100 different GJB2 mutations have been identified, with the 35delG mutation being the most common in Caucasian populations. Hearing loss typically manifests at birth or in early childhood and ranges from mild to profound.

Key Facts

GJB2 mutations account for up to 50% of nonsyndromic sensorineural hearing loss cases
Over 100 different GJB2 mutations have been identified worldwide
The 35delG mutation is the most common GJB2 mutation in Caucasian populations
GJB2-related hearing loss typically manifests at birth or in early childhood
Hearing loss severity ranges from mild to profound, with profound loss occurring in approximately 40% of cases

Overview

The GJB2 gene, located on chromosome 13q12, encodes the gap junction protein connexin 26, which plays a crucial role in auditory function. First linked to hearing loss in 1997, GJB2 mutations have since been identified as the most common genetic cause of nonsyndromic sensorineural hearing loss worldwide. These mutations follow an autosomal recessive inheritance pattern, meaning both parents must carry a mutation for a child to be affected. The prevalence varies significantly across populations, with carrier rates ranging from 1 in 35 in some Mediterranean populations to 1 in 100 in Asian populations. Genetic testing for GJB2 mutations became clinically available in the early 2000s, revolutionizing diagnosis and genetic counseling for families with hereditary hearing loss.

How It Works

GJB2 mutations cause hearing loss by disrupting the normal function of connexin 26, a protein that forms gap junctions between supporting cells in the cochlea. These gap junctions create channels that allow potassium ions (K+) to flow from hair cells back to the endolymph, completing the potassium recycling cycle essential for auditory transduction. When connexin 26 is defective due to GJB2 mutations, potassium accumulates in the supporting cells, leading to toxic levels that damage hair cells and ultimately cause their death. The specific mutation type determines the severity of hearing loss, with truncating mutations (like 35delG) typically causing more severe impairment than missense mutations. The process begins during fetal development and continues postnatally, explaining why hearing loss is usually congenital or early-onset.

Why It Matters

Understanding GJB2-related hearing loss has transformed clinical practice, enabling early diagnosis through newborn hearing screening combined with genetic testing. This knowledge allows for timely intervention with hearing aids or cochlear implants, significantly improving language development outcomes. Genetic counseling based on GJB2 testing helps families understand recurrence risks and make informed reproductive decisions. Research into connexin 26 function has also advanced our understanding of cochlear physiology and opened avenues for potential gene therapies. The high prevalence of GJB2 mutations makes this a public health priority, with many countries incorporating GJB2 testing into standard care for children with hearing loss.